| Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model M Haghi, PM Young, D Traini, R Jaiswal, J Gong, M Bebawy Drug development and industrial pharmacy 36 (10), 1207-1214, 2010 | 141 | 2010 |
| Autophagy activation in asthma airways remodeling KD McAlinden, DA Deshpande, S Ghavami, D Xenaki, SS Sohal, ... American journal of respiratory cell and molecular biology 60 (5), 541-553, 2019 | 122 | 2019 |
| Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery S Scalia, M Haghi, V Losi, V Trotta, PM Young, D Traini European Journal of Pharmaceutical Sciences 49 (2), 278-285, 2013 | 84 | 2013 |
| Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations M Haghi, HX Ong, D Traini, P Young Pharmacology & therapeutics 144 (3), 235-252, 2014 | 80 | 2014 |
| Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia M Haghi, D Traini, M Bebawy, PM Young Molecular Pharmaceutics 9 (6), 1717-1726, 2012 | 72 | 2012 |
| Targeting chronic inflammatory lung diseases using advanced drug delivery systems K Dua, PM Hansbro, R Wadhwa, M Haghi, LG Pont, KA Williams Academic Press, 2020 | 59 | 2020 |
| Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1β treatment: a novel role for CCL20 in chronic mucus hypersecretion A Faiz, M Weckmann, H Tasena, CJ Vermeulen, M Van den Berge, ... European Respiratory Journal 52 (2), 2018 | 49 | 2018 |
| In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation V Trotta, WH Lee, CY Loo, M Haghi, PM Young, S Scalia, D Traini International journal of pharmaceutics 491 (1-2), 190-197, 2015 | 46 | 2015 |
| In Vitro Cell Integrated Impactor Deposition Methodology for the Study of Aerodynamically Relevant Size Fractions from Commercial Pressurised Metered Dose … M Haghi, D Traini, P Young Pharmaceutical research 31, 1779-1787, 2014 | 45 | 2014 |
| Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection S Arora, M Haghi, CY Loo, D Traini, PM Young, S Jain Molecular pharmaceutics 12 (6), 2001-2009, 2015 | 38 | 2015 |
| Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability S Arora, M Haghi, PM Young, M Kappl, D Traini, S Jain Expert opinion on drug delivery 13 (2), 183-193, 2016 | 34 | 2016 |
| Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and … DA Lewis, PM Young, F Buttini, T Church, P Colombo, B Forbes, M Haghi, ... European Journal of Pharmaceutics and Biopharmaceutics 86 (1), 31-37, 2014 | 34 | 2014 |
| Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies L Marin, D Traini, M Bebawy, P Colombo, F Buttini, M Haghi, HX Ong, ... European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 566-572, 2013 | 34 | 2013 |
| Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate B Sheikholeslami, NW Lam, K Dua, M Haghi Life Sciences 300, 120574, 2022 | 31 | 2022 |
| Fluticasone uptake across Calu‐3 cells is mediated by salmeterol when deposited as a combination powder inhaler M Haghi, D Traini, DS Postma, M Bebawy, PM Young Respirology 18 (8), 1197-1201, 2013 | 30 | 2013 |
| Salbutamol sulfate absorption across Calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs M Mamlouk, PM Young, M Bebawy, M Haghi, S Mamlouk, V Mulay, ... Journal of Asthma 50 (4), 334-341, 2013 | 25 | 2013 |
| Delivery of theophylline as dry powder for inhalation B Zhu, M Haghi, A Nguyen, M Goud, S Yeung, PM Young, D Traini asian journal of pharmaceutical sciences 10 (6), 520-527, 2015 | 24 | 2015 |
| Mono-and cocultures of bronchial and alveolar epithelial cells respond differently to proinflammatory stimuli and their modulation by salbutamol and budesonide M Haghi, M Hittinger, Q Zeng, B Oliver, D Traini, PM Young, H Huwer, ... Molecular pharmaceutics 12 (8), 2625-2632, 2015 | 24 | 2015 |
| Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles … M Haghi, M Bebawy, P Colombo, B Forbes, DA Lewis, R Salama, D Traini, ... European Journal of Pharmaceutics and Biopharmaceutics 86 (1), 38-45, 2014 | 24 | 2014 |
| Antibiotic transport across bronchial epithelial cells: Effects of molecular weight, LogP and apparent permeability M Stigliani, M Haghi, P Russo, PM Young, D Traini European Journal of Pharmaceutical Sciences 83, 45-51, 2016 | 21 | 2016 |
Daniela TrainiUniversity of SydneyVerified email at sydney.edu.au
